CERETEC - 17156-022-05 - (exametazime)

Alphabetical Index


Drug Information of CERETEC

Product NDC: 17156-022
Proprietary Name: CERETEC
Non Proprietary Name: exametazime
Active Ingredient(s): .5    mg/5mL & nbsp;   exametazime
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of CERETEC

Product NDC: 17156-022
Labeler Name: Medi-Physics Inc. dba GE Healthcare.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019829
Marketing Category: NDA
Start Marketing Date: 19881230

Package Information of CERETEC

Package NDC: 17156-022-05
Package Description: 5 VIAL in 1 KIT (17156-022-05) > 5 mL in 1 VIAL

NDC Information of CERETEC

NDC Code 17156-022-05
Proprietary Name CERETEC
Package Description 5 VIAL in 1 KIT (17156-022-05) > 5 mL in 1 VIAL
Product NDC 17156-022
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name exametazime
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19881230
Marketing Category Name NDA
Labeler Name Medi-Physics Inc. dba GE Healthcare.
Substance Name EXAMETAZIME
Strength Number .5
Strength Unit mg/5mL
Pharmaceutical Classes

Complete Information of CERETEC


General Information